New York,,, March 25, 2025 / Prnewswire/ -pomerantz llp is Walgreens Boots Alliance, Inc. (NASDAQ: NASDAQ: WBA)) And certain officers. Collective action USA District Court in the northern region IllinoisAnd using a Doket according to 25-CV-01058 on behalf of a class consisting of all people and organizations other than the accused who purchased or acquired common stocks. April 2, 2020 and January 16, 2025The two dates are included (“class period”), the defendant’s violation of the Federal Securities Law, and in 1934, the Securities and Exchange Act 10 (B) and 20 (a) pursue the remedies (“exchange law”) and the rules. 10b-5 companies and some of the best officials.
If you are an investor who purchased or purchased a common stock during class during the class March 31, 2025 Ask the court to appoint you as a class manuscript. A copy of complaints can be obtained www.pomerantzlaw.com. To discuss this measure, please contact us Daniel Payon ~ (Email protection) Or 646-581-9980 (or 888.4-POMLAW), tolls, ext. 7980. People who contact us by email are recommended to include mail addresses, phone numbers, and number of purchases.
(Click here to see information about joining group behavior)
WALGREENS operates as a medical, pharmacy and retail company. USA ( “we”), uk,,, germanyInternational. The company’s operation is carried out through three reporting sectors: US retail pharmacy, international and US health care. The US retail pharmacy division includes Walgreens Business, which includes retail pharmacy operation, health and wellness services, professional and home delivery pharmacy services. Much of the sales of the US retail pharmacy sector comes from prescription drugs, most of which are repaid by a third -party payment person, including federal medical programs.
Regarding prescription drugs, Walgreens must comply with various federal laws, including the 1970 comprehensive drug abuse prevention and control method (“Control Substance Act” or “CSA”), 21 USC § 1501-904. Depending on CSA, all registrants, including pharmacies, should provide effective control and procedures to prevent theft and conversion of controlled materials, and the controlled material may be distributed according to prescription prescriptions for “legal medical purposes for legal medical purposes,” and may be published by “individual practitioners who act in professional practices.” See CFR § 1306.04 (a), and when you seek repayment of these drugs in federal medical programs, you must submit an accurate claim to avoid penalties in 1863. fraud Against the government. Specifically, the FCA provides a person who intentionally presents or offers false or fraudulent claims for payment or approval. Or (2) The cause of intentionally creating or using false records for false or fraudulent claims is responsible for damages. 31 USC § 3279 (a) (1) (a)-(b).
Compliance with CSA and FCA is especially associated with the operation of Walgreens in the context of opioid epidemics. Over the past 20 years, opioids have developed into a national public health crisis that devastated the community throughout the United States in 2017, and the opioid crisis declared a public health emergency in accordance with Article 319 of the Public Health Service Act. It was revealed. Since the beginning of the infectious disease, overdose of opioids and non -fatal opioids has been a significant burden on government, health systems and families. In response to this crisis, Walgreens explained, “It is a leader who provides education and resources as well as implementing policies and procedures in classes that will help to fight opioid misuse and abuse.” In addition, as part of the ostensible commitment to environmental, social and governance (“ESG”) progress, the company was proud of the health -centered sustainability strategy focused on a healthy community, a healthy planet, a healthy and inclusive work and a sustainable market.
Despite these statements, Walgreens has been subject to various legal procedures in connection with the contribution to US Opioid epidemics, including contribution to opioid epidemics (“2013 contract”), and the US Justice Department (“DOJ”) and the US Pharmaceutical Administration do not comply with CSA when the CSA does not comply with CSA. When it was not possible, it was the subject of various legal procedures regarding the contribution to the US Opioid epidemics that reached the US drug implementation administration. From an individual prescribed to others for illegal use, certain opioids for the sale of abuse and illegal cancer markets. likewise, May 2022Walgreens announced that it has reached an opioid settlement. $ 683 million together Florida Solve all arguments related to distribution and distribution of prescription opioid drugs over the company’s pharmacy. A few months later, in November 2022The company has announced that in principle, in principle, in order to solve the claim that Walgreens has misrepresented the OPIOID Painkillers’ prescription, it agreed to a multinational opioid settlement framework. $ 49.5 billion You must pay for 15 years during treatment. ~ Inside April 2024,, Philadelphias He announced that he reached an agreement on Walgreens in a 2021 lawsuit against the company’s role in supplying and ending the opioid addiction crisis. PhiladelphiaAs Walgreens pays to the city $ 110 million Rewards over five years. Recently September 2024Walgreens Baltimore Solve the company’s claim to the role of fueling opioid infectious diseases. BaltimoreAs Walgreens agreed to pay the city $ 80 million.
As a result, Walgreens made various promises to implement the actions designed to detect and prevent the conversion of control materials. For example, according to the 2013 contract, Walgreens said that it will train the pharmacist to ensure that pharmacists comply with CSAs to identify the timely flag of potential shifts and to maintain the “constraint integrity department” to adjust the compliance efforts related to control substances. But as investors learned, Walgreens continued to participate in violating CSA and FCAs in relation to prescription drugs.
dissatisfaction claim During the class, the defendant had practically false and misunderstandings about the company’s business, operation and outlook. Specifically, the defendant has made a statement that has a false and/or misunderstanding, or has not disclosed the following. (i) Contrary to the company’s tastes on improving regulations, Walgreens continued to participate in a wide range of violations of federal law, which dominates prescription and repayment. (ii) The above -described behavior will increase the risk of further regulatory investigation, civil liability and reputation damage when it is released. (III) Walgreens’ income from prescription drugs was impossible to last from illegal acts. And as a result, the company’s public statement was actually false and misleading at all relevant times.
~ January 17, 2025DOJ announced a civil complaint (“DOJ complaint”) claiming that Walgreens violated the false claims (FCA) against many prescriptions of various federal health care programs after distributing millions of illegal prescriptions that violated the Control Substance Act (CSA). Specifically, DOJ’s complaints claim It is roughly August 2012 Through this, WALGREENS has deliberately filled, not valid, or in a general professional working process, and has not been issued in a general professional practical process for controlled materials that lack legitimate medical purposes. And a trinity, including a prescription for the combination of the drug. Claimed Walgreens recognizes the obligation to take the responsibility and conflicts with the previous promise of “business practices,” “” “” “” “” to implement or maintain various regulations. “
Following DOJ’s announcement, Walgreens’ stock price has fallen. $ 1.56 Compared to the following two trading sessions, 12.06%per week, $ 11.37 Per week January 21, 2025.
Pomerantz llp with an office New York,,, Chicago,,, Los Angeles,,, London,,, flyand Tel AvivIt is recognized as one of the premiere companies in the field of litigation in companies, securities and monopoly classes. Established late Abraham L. PorterKnown as Dean of Group Action Bar, Pomerantz has pioneered the field of securities. Today, 85 years later, Pomerantz continues to fight for the rights of securities victims by continuing the tradition he has established. fraudTrust obligations violations and corporate illegal acts. The company recovered billions of dollars of damages on behalf of class members. see www.pomlaw.com.
Lawyer advertisement. Previous results do not guarantee similar results.
Contact:
Daniel Payon
Pomeranz LLP
(Email protection)
646-581-9980. 7980
Source Pomeranz LLP
